Newmark and Avison Young lease 40,288 s/f lease to Collegium Pharm. at DivcoWest’s One Lincoln

Boston, MA According to Divco- West, Collegium Pharmaceutical has signed a lease for 40,288 s/f on floors 11 and 12 at One Lincoln in the Financial District. The 36-story, 1.1 million s/f Class A office tower completed a renewal in 2025 and now serves as a landmark next-generation workplace for world-class established and growth stage companies.

Newmark’s Gil Dailey and Dave Martel represented DivcoWest in the transaction, with Avison Young’s Justin Dziama and Connor Hayes representing Collegium Pharmaceutical.

“Welcoming a life sciences leader like Collegium Pharmaceutical to One Lincoln speaks to the versatility of this building and its ability to serve companies across industries,” said Mark Roopenian, managing director at DivcoWest. “Collegium’s decision reflects everything One Lincoln has to offer, from an elevated workplace experience to an unmatched location, only steps from South Station. As companies continue to prioritize spaces that support collaboration and employee experience, we’re proud to offer a workplace that meets those evolving needs and look forward to this partnership.”

Collegium’s arrival adds a life science presence to a tenant roster that already spans several industries. One Lincoln is home to HarbourVest, a leading global private markets firm; Lovable, a fast-growing AI platform; law firm Sherin and Lodgen; advisory firm CFGI; and flexible-workspace provider WeWork, among others. That breadth of tenancy demonstrates the building’s ability to support companies at every stage and across sectors, from global financial services and legal and professional services firms to high-growth technology and now, life science companies.

“This relocation reflects a broader trend we’re seeing across Greater Boston,” said Justin Dziama, Principal at Avison Young, who represented Collegium in the transaction. “As market conditions have shifted, companies are taking advantage of the opportunity to upgrade their workplace experience, improve accessibility for employees and establish a stronger presence in the urban core. For Collegium, One Lincoln provided the chance to accomplish all of those goals in one move.”

Relaunched in late 2025 following a comprehensive repositioning, One Lincoln was redesigned to meet the evolving needs of today’s workforce. The building features hospitality-driven design, a best-in-class amenity package featuring a two-story health and wellness club, exclusive tenant dining options, a full game room and wellness suite, and a rooftop basketball and pickleball court plus flexible conference and meeting spaces, all delivering seamless connectivity and an elevated, service-led tenant experience.

Collegium is a biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system (CNS) and pain conditions. Drawn by the building’s central location, connectivity to South Station, ease of accessibility, and elevated workplace experience, the company selected One Lincoln to establish its new headquarters.

“Collegium’s lease underscores the momentum behind One Lincoln and the continued demand for well-located, highly activated office environments,” said Gil Dailey, executive managing director at Newmark, who represented DivcoWest in the transaction. “The building has quickly established itself as a compelling option for tenants seeking a dynamic Boston workplace that supports both their people and their business.”

One Lincoln is at the intersection of I-93 and the Massachusetts Tpke., steps from South Station with its Amtrak, MBTA subway, commuter rail and bus connections, and within five miles of Boston Logan International Airport.